Catheter-assisted tumor treatment

• US 10,149,968 B2
• Filed: 12/17/2015
• Issued: 12/11/2018
• Est. Priority Date: 06/14/2013
• Status: Active Grant

• Current Assignee: ArtVentive Medical Group Inc
• Original Assignee: ArtVentive Medical Group Inc
• Inventors: Rudakov, Leon
• Primary Examiner(s): Osinski, Bradley J
• Assistant Examiner(s): Shah, Nilay
• Application Number:
  US14/973,414
• Publication Number:
  US 20160101271A1
• Time in Patent Office: 1,090 Days
• CPC Class Codes: A61B 17/1204 temporary occlusion
• CPC Class Codes: A61B 17/12109 in a blood vessel
• CPC Class Codes: A61B 17/1214 Coils or wires
• CPC Class Codes: A61B 17/1215 comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
• CPC Class Codes: A61B 17/12172 having a pre-set deployed three-dimensional shape methods of manufacturing A61B2017/00526
• CPC Class Codes: A61B 17/12177 comprising additional materials, e.g. thrombogenic, having filaments, having fibers or being coated
• CPC Class Codes: A61B 17/12186 liquid materials adapted to be injected
• CPC Class Codes: A61B 2017/00893 pharmaceutically effective
• CPC Class Codes: A61B 2017/12054 Details concerning the detachment of the occluding device from the introduction device
• CPC Class Codes: A61M 2202/0208 Oxygen
• CPC Class Codes: A61M 2205/04 implanted
• CPC Class Codes: A61M 2205/052 infrared
• CPC Class Codes: A61M 31/007 Injectors for solid bodies, e.g. suppositories
• CPC Class Codes: A61M 39/22 Valves or arrangement of valves A61M39/02, A61M39/0247, A61M39/16 take precedence; regulating valves in infusion systems A61M5/16881; in devices worn by the patient for the reception of urine, faeces, catamenial or other discharge, or in colostomy devices A61F5/4405
• CPC Class Codes: A61N 2005/1003 having means for centering a radioactive source within the lumen, e.g. balloons
• CPC Class Codes: A61N 5/1002 Intraluminal radiation therapy

Abstract

A method for treating a subject diagnosed with a cancer or other disorder comprising a hyperproliferative tissue is described herein. The method includes localized delivery of a material which contains a therapeutically effective agent and/or moiety. The localized delivery of the agent is achieved using a catheter-based delivery system and an implant. An implant can include a support component, a cover component, and a valve component. The valve component can be operable to permit flow through the implant. The implant can be delivered on a catheter, with one of the ends of the implant being selectively expanded to permit temporary occlusion of a vessel while delivering a material through the valve component to a downstream target region. The other end of the implant can thereafter be released such that the implant occludes the vessel, or the implant can be removed from the vessel entirely.

Claims

1. A method for treating a subject diagnosed with a cancer, comprising:

advancing an implant to a target region of a body lumen which is near or contains the cancer, the implant having first and second sections engaged with a catheter at respective first and second engagement points;

releasing the implant first section from engagement with the catheter at the first engagement point;

permitting the implant first section to expand against a lumen wall at the target region such that the lumen becomes at least substantially occluded; and

injecting a therapeutic material through a portion of the implant while the implant second section remains unexpanded and engaged with the catheter, wherein the material is effective to treat the cancer.

2. The method of claim 1, further comprising, prior to releasing the implant first section, releasing a blocking implant into contact against the lumen wall downstream of the target region, the blocking implant occluding flow through the lumen beyond the target region.

3. The method of claim 2, further comprising, after injecting the material, allowing the material to flow into the target region, and removing the blocking implant from the lumen.

4. The method of claim 1, wherein the material comprises a nanoparticle, a radioembolic composition, a blood substitute comprising oxygen, a photothermal agent, or a chemotherapeutic.

5. The method of claim 4, wherein the nanoparticle is a gold nanoparticle or a gold-iron oxide alloy nanoparticle.

6. The method of claim 4, wherein the nanoparticle is linked to a pH low-insertion peptide or to an antibody which binds an antigen expressed on a cell of the cancer.

7. The method of claim 4, wherein the catheter comprises an optical fiber which extends from a proximal to a distal end of the catheter and wherein the optical fiber can emit infrared light from the distal end of the catheter.

8. The method of claim 7, wherein the optical fiber is activated to emit infrared light from the distal end of the catheter after injecting the material into the target region or after injecting the material into the target region and before removing a blocking implant from the lumen.

9. The method of claim 1, wherein the therapeutic material comprises a radiosensitizer.

10. The method of claim 9, further comprising administering to the subject x-irradiation or γ

-irradiation, wherein the x-irradiation or γ

-irradiation is administered externally or internally through the catheter to the target region.

11. The method of claim 1, wherein the injecting comprises advancing the material through the implant first section.

12. The method of claim 1, comprising releasing the implant second section from engagement with the catheter, and permitting the implant second section to expand.

13. The method of claim 1, wherein the implant second section comprises an implant proximal portion, and wherein injecting comprises injecting a fluid into the implant proximal portion.

14. The method of claim 1, comprising removing the implant and the catheter from the body lumen.